Loading company details...
Latest Form 4 (Mar 11, 2024): Merck & Co., Inc. (10% Owner): Purchase of 21,397,205 shares, $492.14M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 11, 2024 | Merck & Co., Inc. | Purchase | 21,397,205 | $492.14M |
| Mar 11, 2024 | New Leaf Biopharma Opportunities II, L.P. | Disposition to Issuer | 1,463,386 | n/a |
| Mar 11, 2024 | Lauren P. Silvernail | Disposition to Issuer | 5,000 | n/a |
| Mar 11, 2024 | Ronald Hunt | Grant/Award | 424 | n/a |
| Mar 11, 2024 | Luke Nathaniel Walker, Chief Medical Officer | Disposition to Issuer | 135,000 | n/a |
| Mar 11, 2024 | Scott Dunseth Myers | Disposition to Issuer | 22,665 | n/a |
| Mar 11, 2024 | Mark Chin | Grant/Award | 424 | n/a |
| Mar 11, 2024 | Jonathan G. Drachman | Grant/Award | 415 | n/a |
| Mar 11, 2024 | Andrew R. Robbins | Disposition to Issuer | 5,000 | n/a |
| Mar 11, 2024 | Frank J. Lanza, Principal Fin. & Acctng Ofc. | Disposition to Issuer | 18,734 | n/a |